Results 81 to 90 of about 2,136 (172)

Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen

, 2011
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), currently considered to originate from immature plasmacytoid dendritic cells (DC), is a rare and aggressive CD4+CD56+ neoplasm that frequently involves the skin and bone marrow.
Takayuki Takahashi, Seiji Nagano, Kiminari Ito, Yukihiro Imai, Takayuki Ishikawa, Kyoko Maruyama, Daichi Inoue, Hayato Maruoka, Kazunari Aoki   +8 more
core   +1 more source

Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation

eJHaem
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee, Shawn P. Griffin, Deepa Jeyakumar, Ashley Gamayo, Sherif A. Rezk, Kiran Naqvi   +5 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm

Kansas Journal of Medicine, 2014
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It manifests as cutaneous and bone marrow involvement and leukemic spread. It represents 0.7% of primary cutaneous lymphomas. Recently, it was established as a distinct entity.
Rami Jabbour, Jimmy Doumit, Janah Maddah, Fady Nasr   +3 more
openaire   +2 more sources

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm

, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incidence is unknown due to lack of diagnostic criteria. Typically, it involves skin and bone marrow and less likely, lymph nodes and visceral organs.
Taylor, Katrina, Bhat, Alina, Mohammadi, Oranus   +2 more
core  

Blastic plasmacytoid dendritic cell neoplasm in an elderly woman

, 2013
Blastic plasmacytoid dendritic cell neoplasm (a.k.a. NK cell lymphoma, CD4+CD56+ haematodermic neoplasm) is a rare aggressive tumour that arises from plasmacytoid dendritic cell precursors.
Fazril Zayadi
core  

Blastic Plasmacytoid Dendritic Cell Neoplasm: Report of a Case

, 2012
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), also known as CD4+/CD56+ hematodermic neoplasm, is a rare, highly aggressive hematopoietic malignancy characterized by cutaneous, lymph node and bone marrow involvement, high risk of a leukemic ...
MASCOLO, MASSIMO, Lucia Gallo, SCALVENZI, MASSIMILIANO, Franco Palmisano, DE ROSA, GAETANO, Orlando Zagaria   +5 more
core  

Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity

Indian Journal of Pathology and Microbiology, 2015
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive neoplasm classified under "acute myeloid leukemia (AML) and related precursor neoplasm" by current WHO classification.
Sumaira Qayoom, Garima Durga, Seena George, Khaliqur Rahman   +3 more
doaj   +1 more source

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz, A. Camila Martín-Zamora, Betzabé Rojas-Mena   +2 more
doaj  

Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome

, 2017
Background: Myelodysplastic syndromes with chromosome 5 long arm deletion (5q-MDS) may benefit from lenalidomide treatment. However, unresponsive patients have a high risk for clonal evolution and progression to acute myeloid leukemia.
A. Freyrie, FERLA, VALERIA, N. S. Fracchiolla, G. Reda, Alessanda Iurlo, Bruno Fattizzo, Agostino Cortelezzi, Valeria Ferla, A. Cortelezzi, Alessandra Freyrie, Nicola Fracchiolla, Gianluigi Reda, A. Iurlo, B. Fattizzo   +13 more
core   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source